Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

FOXA1 overexpression suppresses interferon signaling and immune response in cancer
Yundong He, Liguo Wang, Ting Wei, et al.
Journal of Clinical Investigation (2021) Vol. 131, Iss. 14
Open Access | Times Cited: 62

Showing 1-25 of 62 citing articles:

Targeting signaling pathways in prostate cancer: mechanisms and clinical trials
Yundong He, Weidong Xu, Yu‐Tian Xiao, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 111
Virus-like nanoparticles as a theranostic platform for cancer
Kyeong Rok Kim, Ae Sol Lee, Sumin Kim, et al.
Frontiers in Bioengineering and Biotechnology (2023) Vol. 10
Open Access | Times Cited: 23
Loss of SYNCRIP unleashes APOBEC-driven mutagenesis, tumor heterogeneity, and AR-targeted therapy resistance in prostate cancer
Xiaoling Li, Yunguan Wang, Su Deng, et al.
Cancer Cell (2023) Vol. 41, Iss. 8, pp. 1427-1449.e12
Open Access | Times Cited: 20
Molecular Mechanisms of Prostate Cancer Development in the Precision Medicine Era: A Comprehensive Review
Shigekatsu Maekawa, Ryo Takata, Wataru Obara
Cancers (2024) Vol. 16, Iss. 3, pp. 523-523
Open Access | Times Cited: 8
Multimodal analysis of cfDNA methylomes for early detecting esophageal squamous cell carcinoma and precancerous lesions
Jiaqi Liu, Lijun Dai, Qiang Wang, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 6
Tumor-intrinsic regulators of the immune-cold microenvironment of prostate cancer
Lourdes T Brea, Jindan Yu
Trends in Endocrinology and Metabolism (2025)
Closed Access
FOXA1: A Pioneer of Nuclear Receptor Action in Breast Cancer
Darcie D. Seachrist, Lindsey J. Anstine, Ruth A. Keri
Cancers (2021) Vol. 13, Iss. 20, pp. 5205-5205
Open Access | Times Cited: 49
Inhibition of EZH2 transactivation function sensitizes solid tumors to genotoxic stress
Yiji Liao, Chen-Hao Chen, Tengfei Xiao, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 3
Open Access | Times Cited: 35
AKT Blocks SIK1-Mediated Repression of STAT3 to Promote Breast Tumorigenesis
Zicheng Sun, Qiwei Jiang, Bing Gao, et al.
Cancer Research (2023) Vol. 83, Iss. 8, pp. 1264-1279
Open Access | Times Cited: 18
hsa_circ_0007919 induces LIG1 transcription by binding to FOXA1/TET1 to enhance the DNA damage response and promote gemcitabine resistance in pancreatic ductal adenocarcinoma
Lei Xu, Xiao Ma, Xiuzhong Zhang, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 16
FOXA1 repression drives lineage plasticity and immune heterogeneity in bladder cancers with squamous differentiation
Joshua I. Warrick, Wenhuo Hu, Hironobu Yamashita, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 25
RAD21 amplification epigenetically suppresses interferon signaling to promote immune evasion in ovarian cancer
Peng Deng, Zining Wang, Jinghong Chen, et al.
Journal of Clinical Investigation (2022) Vol. 132, Iss. 22
Open Access | Times Cited: 22
The Immunotherapy and Immunosuppressive Signaling in Therapy-Resistant Prostate Cancer
Pengfei Xu, Logan J. Wasielewski, Joy C. Yang, et al.
Biomedicines (2022) Vol. 10, Iss. 8, pp. 1778-1778
Open Access | Times Cited: 21
The Role of FOXA1 in Human Normal Development and Its Functions in Sex Hormone-Related Cancers
Juan Zhu, Yunjian Wei, Fangnan Deng, et al.
Frontiers in Bioscience-Landmark (2024) Vol. 29, Iss. 6, pp. 225-225
Open Access | Times Cited: 3
Genetic dysregulation of immunologic and oncogenic signaling pathways associated with tumor-intrinsic immune resistance: a molecular basis for combination targeted therapy-immunotherapy for cancer
Kristian M. Hargadon
Cellular and Molecular Life Sciences (2023) Vol. 80, Iss. 2
Open Access | Times Cited: 10
Interferon Signaling in Estrogen Receptor–positive Breast Cancer: A Revitalized Topic
Xiaoyong Fu, Carmine De Angelis, Rachel Schiff
Endocrinology (2021) Vol. 163, Iss. 1
Open Access | Times Cited: 24
FOXA1 prevents nutrients deprivation induced autophagic cell death through inducing loss of imprinting of IGF2 in lung adenocarcinoma
Junjun Li, Yongchang Zhang, Li Wang, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 8
Open Access | Times Cited: 16
Epigenomic mapping identifies an enhancer repertoire that regulates cell identity in bladder cancer through distinct transcription factor networks
Hélène Neyret‐Kahn, Jacqueline Fontugne, Xiang Yu Meng, et al.
Oncogene (2023) Vol. 42, Iss. 19, pp. 1524-1542
Open Access | Times Cited: 9
Immunotherapy in Prostate Cancer: State of Art and New Therapeutic Perspectives
Felicia Maria Maselli, Francesco Giuliani, Carmelo Laface, et al.
Current Oncology (2023) Vol. 30, Iss. 6, pp. 5769-5794
Open Access | Times Cited: 9
Gut Bacteroides act in a microbial consortium to cause susceptibility to severe malaria
Rabindra K. Mandal, Anita Mandal, Joshua E. Denny, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 8
HNRNPA2B1 promotes oral squamous cell carcinogenesis via m6A‐dependent stabilization of FOXQ1 mRNA stability
Xi Wang, Min Zhi, Wei Zhao, et al.
IUBMB Life (2024) Vol. 76, Iss. 7, pp. 437-450
Closed Access | Times Cited: 2
Master Transcription Factor Reprogramming Unleashes Selective Translation Promoting Castration Resistance and Immune Evasion in Lethal Prostate Cancer
Sandra Santasusagna, Shijia Zhu, Vijayakumar Jawalagatti, et al.
Cancer Discovery (2023) Vol. 13, Iss. 12, pp. 2584-2609
Open Access | Times Cited: 7
Chromatin accessibility and pioneer factor FOXA1 restrict glucocorticoid receptor action in prostate cancer
Laura Helminen, Jasmin Huttunen, Melina Tulonen, et al.
Nucleic Acids Research (2023) Vol. 52, Iss. 2, pp. 625-642
Open Access | Times Cited: 7
FOXA1 inhibits hypoxia programs through transcriptional repression of HIF1A
Xiaohai Wang, Lourdes T Brea, Xiaodong Lü, et al.
Oncogene (2022) Vol. 41, Iss. 37, pp. 4259-4270
Open Access | Times Cited: 11
LPCAT1 is transcriptionally regulated by FOXA1 to promote breast cancer progression and paclitaxel resistance
Huayi Zhang, Yaqin Zheng
Oncology Letters (2023) Vol. 25, Iss. 4
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top